Gonoshasthaya Kendra opens plasma centre to treat Covid-19 in capital
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
THURSDAY, MAY 19, 2022
THURSDAY, MAY 19, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Gonoshasthaya Kendra opens plasma centre to treat Covid-19 in capital

Covid-19 in Bangladesh

TBS Report
15 August, 2020, 09:50 pm
Last modified: 15 August, 2020, 09:58 pm

Related News

  • China relaxes some Covid test rules for US, other travellers
  • New York Times pauses return to office for workers
  • S Korea says it will spare no effort to help North Korea amid Covid outbreak
  • Kim Jong Un orders North Korea military to 'stabilise' drug supply amid Covid outbreak
  • RMCH shuts down its corona unit

Gonoshasthaya Kendra opens plasma centre to treat Covid-19 in capital

After taking blood from a donor who recovered from Covid-19, experts will separate the plasma in a lab and give it to a critical patient. It will build antibodies against the coronavirus in the patient’s body

TBS Report
15 August, 2020, 09:50 pm
Last modified: 15 August, 2020, 09:58 pm
Photo: Collected
Photo: Collected

Gonoshasthaya Kendra (GK) invented the antibody testing kit but it could not see the light because of the dilly dallying of the government. GK has lost about Tk10 crore because of this, said GK founder Dr Zafrullah Chowdhury.

He made the remarks while inaugurating their Plasma Center at Gonoshasthaya Nagar Hospital in the Dhanmondi area of the capital on Saturday.

"Following us, several countries made and marketed an antibody kit. But due to the lengthy time taken by our government, the Gonoshasthaya Kendra, as well as the country, had to face losses," said Dr Zafrullah.

"The government initially failed to do the right work and made several wrong decisions. They only focus on making policy and avoid their proper duty. Consequently, people have to suffer a lot", he added.

Attending the program as chief guest, hematologist and BMT physician of Dhaka Medical College Prof Dr MA Khan said, "In April, around 60 countries in the world introduced plasma therapy. There are two kinds of plasma therapy — plasmapheresis and plasma separation. Plasmapheresis is much more expensive than plasma separation."

Dr Khan said the GK will use the plasma separation method which will be cost effective and affordable. Therefore the common people will be able to take this therapy. This can save the lives of many elderly Covid-19 patients.

"In Bangladesh, plasma therapy is given to the patient at the eleventh hour, which is the wrong time and situation. It has to be given at an early stage of treatment", said Dr Khan.

Dr Zafrullah said, "Plasma therapy is very effective treatment as no drug has been proven to be safe and effective for treating Covid-19. When I was critically ill with Covid-19, I was given plasma therapy and as a result I recovered."

Replying to a query, he said, "Remdesivir cannot cure Covid-19. It only reduces the time of treatment."

The expert explained that a 450ml bag of blood contains approximately 200ml Red blood cells (RBC), 150ml platelets and 100ml plasma.

After taking blood from a donor who recovered from Covid-19, experts will separate the plasma in a lab and give it to a critical patient. It will build antibodies against the novel coronavirus in the patient's body.

The US Food and Drug Administration approved the use of plasma from recovered patients to treat people who are critically ill with Covid-19.  Use of plasma is an interim approach of treatment until the availability of hyper-immune globulin, drugs and vaccines.

Top News

Gonoshasthaya Kendra / Plasma centre / COVID-19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Finance Minister AHM Mustafa Kamal, Photo: TBS
    Annual foreign debts can be paid with two months’ remittance: Finance minister
  • Falling trade barriers and hyper-efficient logistics produced an age of abundance for many. But the last four years have brought an escalating series of disruptions.Source: Bloomberg
    Age of scarcity begins with $1.6 trillion hit to world economy
  • Turkey's President Tayyip Erdogan holds a news conference during the NATO summit at the Alliance's headquarters in Brussels, Belgium on 14 June  2021. Photo: Reuters
    Turkey has told allies it's a 'no' to Sweden and Finland's NATO bid - Erdogan

MOST VIEWED

  • 35 people test positive for Covid-19 in 24 hours
    35 people test positive for Covid-19 in 24 hours
  • Illustration: Collected
    22 Covid cases reported in 24hrs
  • Photo collected from Guardian
    32 Covid cases reported in 24 hours
  • 37 test positive for Covid-19 in 24 hours
    37 test positive for Covid-19 in 24 hours
  • No Covid death, 33 cases reported in 24 hours
    No Covid death, 33 cases reported in 24 hours
  • Zero Covid death, 22 cases reported in 24 hours
    Zero Covid death, 22 cases reported in 24 hours

Related News

  • China relaxes some Covid test rules for US, other travellers
  • New York Times pauses return to office for workers
  • S Korea says it will spare no effort to help North Korea amid Covid outbreak
  • Kim Jong Un orders North Korea military to 'stabilise' drug supply amid Covid outbreak
  • RMCH shuts down its corona unit

Features

Sketch: TBS

'Food inflation is an unavoidable consequence of currency devaluation'

11h | Interviews
The open-browser-tabs question also tells an interviewer how much of an internet native the job applicant might be. Photo: Noor-a-Alam

The best question to ask a job applicant

11h | Pursuit
Illustration: TBS

Ugly business: Politics in workplace

10h | Pursuit
Illustration: TBS

‘Do you have insurance?’: Life of a life insurance agent

13h | Panorama

More Videos from TBS

Putin's strategies to face Nato

Putin's strategies to face Nato

15m | Videos
How many countries have nuclear weapons and how many are there?

How many countries have nuclear weapons and how many are there?

30m | Videos
Dengue fever is rising, so beware

Dengue fever is rising, so beware

40m | Videos
How a university teacher and PHD holder become farmer

How a university teacher and PHD holder become farmer

4h | Videos

Most Read

1
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

2
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
How Bangladesh can achieve edible oil self-sufficiency with local alternatives
Bazaar

How Bangladesh can achieve edible oil self-sufficiency with local alternatives

5
Govt tightens belt to relieve reserve
Economy

Govt tightens belt to relieve reserve

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab